Back
ProShares Nasdaq-100 High Income ETF Vs. Viking Therapeutics Industry Stock Comparison
Sell
19
IQQQ
ProShares Nasdaq-100 High Income ETF
Last Price:
43.00
Seasonality Move:
--
Sell
44
VKTX
Viking Therapeutics
Last Price:
52.96
Seasonality Move:
1.76%
Sell
19
ProShares Nasdaq-100 High Income ETF (IQQQ)
is a Sell
Is ProShares Nasdaq-100 High Income ETF a Buy, Sell or Hold?
- The current ProShares Nasdaq-100 High Income ETF [IQQQ] share price is $42.81. The Score for IQQQ is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- IQQQ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $50.77. The Score for VKTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IQQQ Stock Price Chart
What is ProShares Nasdaq-100 High Income ETF's stock price today?
-
The ProShares Nasdaq-100 High Income ETF share price today is $42.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IQQQ is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $50.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
IQQQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.55 | Buy |
Relative Strength Index (14 RSI): | 65.93 | Buy |
Chaikin Money Flow: | -128 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.05 - 42.59) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.32 | Sell |
Relative Strength Index (14 RSI): | 38.16 | Sell |
Chaikin Money Flow: | 2857375 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.57 - 61.31) | Sell |
Bollinger Bands (100): | (46.52 - 79.44) | Sell |
IQQQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.73 | Buy |
20-day SMA: | 41.96 | Buy |
50-day SMA: | 40.75 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 42.59 | Buy |
20-day EMA: | 42.1 | Buy |
50-day EMA: | 27.72 | Buy |
200-day EMA: | 9.9 | Buy |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.48 | Buy |
20-day SMA: | 54.1 | Sell |
50-day SMA: | 63.93 | Sell |
200-day SMA: | 39 | Buy |
8-day EMA: | 50.61 | Buy |
20-day EMA: | 54.34 | Sell |
50-day EMA: | 59.63 | Sell |
200-day EMA: | 45.62 | Buy |
ProShares Nasdaq-100 High Income ETF Earnings Growth & IQQQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
ProShares Nasdaq-100 High Income ETF Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |